<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36690284</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1740</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><PubDate><Year>2023</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Progress in cardiovascular diseases</Title><ISOAbbreviation>Prog Cardiovasc Dis</ISOAbbreviation></Journal><ArticleTitle>The acute and chronic implications of the COVID-19 virus on the cardiovascular system in adults: A systematic review.</ArticleTitle><Pagination><StartPage>31</StartPage><EndPage>37</EndPage><MedlinePgn>31-37</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pcad.2023.01.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0033-0620(23)00004-X</ELocationID><Abstract><AbstractText>Despite coronavirus disease 2019 (COVID-19) primarily being identified as a respiratory illness, some patients who seemingly recovered from initial infection, developed chronic multi-system complications such as cardiovascular (CV), pulmonary and neurological issues leading to multiple organ injuries. However, to date, there is a dearth of understanding of the acute and chronic implications of a COVID-19 infection on the CV system in adults. A systematic review of the literature was conducted according to PRISMA guidelines and prospectively registered via Prospero (ID: CRD42022360444). The MEDLINE Ovid, Cochrane Library and PubMed databases were searched from inception to August 2022. The search strategy keywords and MeSH terms used included: 1) COVID; 2) coronavirus; 3) long COVID; 4) cardiovascular; and 5) cardiovascular disease. Reference lists of all relevant systematic reviews identified were searched for additional studies. A total of 11,332 records were retrieved from database searches, of which 310 records were duplicates. A further 9887 were eliminated following screening of titles and abstracts. After full-text screening of 1135 articles, 9 manuscripts were included for review. The evidence of CV implications post-COVID-19 infection is clear, and this must be addressed with appropriate management strategies that recognise the acute and chronic nature of cardiac injury in COVID-19 patients. Efficacious management strategies will be needed to address long standing issues and morbidity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ashton</LastName><ForeName>Ruth E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Biomedical Research Theme, School of Human Sciences, University of Derby, Derby, UK; Healthy Living for Pandemic Event Protection (HL - PIVOT) Network, Chicago, IL, United States of America. Electronic address: r.ashton@derby.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philips</LastName><ForeName>Bethan E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research and National Institute for Health Research Nottingham Biomedical Research Centre, School of Medicine, University of Nottingham, Derby, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faghy</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Biomedical Research Theme, School of Human Sciences, University of Derby, Derby, UK; Healthy Living for Pandemic Event Protection (HL - PIVOT) Network, Chicago, IL, United States of America; Department of Physical Therapy, College of Applied Sciences, University of Illinois at Chicago, Chicago, IL, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Prog Cardiovasc Dis</MedlineTA><NlmUniqueID>0376442</NlmUniqueID><ISSNLinking>0033-0620</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute illness</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Chronic disease</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>23</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36690284</ArticleId><ArticleId IdType="pmc">PMC9854143</ArticleId><ArticleId IdType="doi">10.1016/j.pcad.2023.01.003</ArticleId><ArticleId IdType="pii">S0033-0620(23)00004-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coccolini F., Cicuttin E., Cremonini C., et al. A pandemic recap: lessons we have learned. World J Emerg Surg. 2021;16(1):46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8430288</ArticleId><ArticleId IdType="pubmed">34507603</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenseth N.C., Dharmarajan G., Li R., et al. Lessons learnt from the COVID-19 pandemic. Front Public Health. 2021;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8365337</ArticleId><ArticleId IdType="pubmed">34409008</ArticleId></ArticleIdList></Reference><Reference><Citation>Boukhris M., Hillani A., Moroni F., et al. Cardiovascular implications of the COVID-19 pandemic: a global perspective. Can J Cardiol. 2020;36(7):1068&#x2013;1080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229739</ArticleId><ArticleId IdType="pubmed">32425328</ArticleId></ArticleIdList></Reference><Reference><Citation>Forman R., Atun R., McKee M., Mossialos E. 12 lessons learned from the management of the coronavirus pandemic. Health Policy. 2020;124(6):577&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227502</ArticleId><ArticleId IdType="pubmed">32425281</ArticleId></ArticleIdList></Reference><Reference><Citation>Organisation, W.H . 2022. Global COVID Stituation 2022. [cited 2022 19th October]</Citation></Reference><Reference><Citation>Missel M., Bernild C., Christensen S.W., Dagyaran I., Berg S.K. It&#x2019;s not just a virus! lived experiences of people diagnosed with COVID-19 infection in Denmark. Qual Health Res. 2021;31(5):822&#x2013;834.</Citation><ArticleIdList><ArticleId IdType="pubmed">33554742</ArticleId></ArticleIdList></Reference><Reference><Citation>Rofail D., McGale N., Podolanczuk A.J., et al. Patient experience of symptoms and impacts of COVID-19: a qualitative investigation with symptomatic outpatients. BMJ Open. 2022;12(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9062460</ArticleId><ArticleId IdType="pubmed">35501077</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyaolu A., Marinkovic A., Prakash S., et al. Post-acute sequelae in COVID-19 survivors: an overview. SN Compr Clin Med. 2022;4(1):91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8985741</ArticleId><ArticleId IdType="pubmed">35411333</ArticleId></ArticleIdList></Reference><Reference><Citation>Welty F.K., Rajai N., Amangurbanova M. Comprehensive review of cardiovascular complications of coronavirus disease 2019 and beneficial treatments. Cardiol Rev. 2022;30(3):145&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983616</ArticleId><ArticleId IdType="pubmed">35384908</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.-J., Ni Z.-Y., Hu Y., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott J., Whitaker M., Bodinier B., et al. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLoS Med. 2021;18(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478234</ArticleId><ArticleId IdType="pubmed">34582457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanne J.P., Bai H., Bernheim A., et al. COVID-19 imaging: what we know now and what remains unknown. Radiology. 2021;299(3):E262&#x2013;e279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7879709</ArticleId><ArticleId IdType="pubmed">33560192</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Long X., Wang X., et al. Radiology indispensable for tracking COVID-19. Diagn Interv Imaging. 2021;102(2):69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685040</ArticleId><ArticleId IdType="pubmed">33281082</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi F., Owen R., Ashton R.E.M., et al. Post-acute COVID syndrome (long COVID): what should radiographers know and the potential impact for imaging services. Radiography (Lond) 2022;28(suppl 1):S93&#x2013;s99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9468096</ArticleId><ArticleId IdType="pubmed">36109264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L., Pennington A.F., Goodman A.B., et al. Underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020-March 2021. Prev Chronic Dis. 2021;18:E66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8269743</ArticleId><ArticleId IdType="pubmed">34197283</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Yang J., Zhao F., et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7087935</ArticleId><ArticleId IdType="pubmed">32161990</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid A., Petrovic M., Akella K., Pareddy A., Velavan S.S. Getting to the heart of the matter: myocardial injury, coagulopathy, and other potential cardiovascular implications of COVID-19. Int J Vasc Med. 2021;2021:6693895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118745</ArticleId><ArticleId IdType="pubmed">34035963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen M.C.H., Skaarup K.G., Lind J.N., et al. Recovery of cardiac function following COVID-19 - ECHOVID-19: a prospective longitudinal cohort study. Eur J Heart Fail. 2021;23(11):1903&#x2013;1912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652600</ArticleId><ArticleId IdType="pubmed">34514713</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochette L., Ghibu S. Mechanics insights of alpha-lipoic acid against cardiovascular diseases during COVID-19 infection. Int J Mol Sci. 2021;22(15)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8348748</ArticleId><ArticleId IdType="pubmed">34360751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ar&#xe9;valos V., Ortega-Paz L., Rodr&#xed;guez-Arias J.J., et al. Acute and chronic effects of COVID-19 on the cardiovascular system. J Cardiovasc Dev Dis. 2021;8(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8541609</ArticleId><ArticleId IdType="pubmed">34677197</ArticleId></ArticleIdList></Reference><Reference><Citation>Samavati L., Uhal B.D. ACE2, much more than just a receptor for SARS-COV-2. Front Cell Infect Microbiol. 2020;10:317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7294848</ArticleId><ArticleId IdType="pubmed">32582574</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M.K., Zidar D.A., Bristow M.R., et al. COVID-19 and cardiovascular disease: from bench to bedside. Circ Res. 2021;128(8):1214&#x2013;1236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Arena R., Bond S., Calvo I.R., et al. Shelter from the cytokine storm: healthy living is a vital preventative strategy in the COVID-19 era. Prog Cardiovasc Dis. 2021;73:56&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8214803</ArticleId><ArticleId IdType="pubmed">34153291</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandoval Y., Januzzi J.L., Jr., Jaffe A.S. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2020;76(10):1244&#x2013;1258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833921</ArticleId><ArticleId IdType="pubmed">32652195</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S., Qin M., Shen B., et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourad Ouzzani H.H., Fedorowicz Zbys, Elmagarmid Ahmed. Rayyan &#x2014; a web and mobile app for systematic reviews. Systematic reviews (2016) Syst Rev. 2016;5(210)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Altman D.G., G&#xf8;tzsche P.C., et al. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian P.T., Higgins J.T., Chandler Jacqueline, et al. 2nd ed. Wiley-Blackwell; 2019. Cochrane Handbook for Systematic Reviews of Interventions.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors J.M., Brooks M.M., Sciurba F.C., et al. Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial. Jama. 2021;326(17):1703&#x2013;1712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8506296</ArticleId><ArticleId IdType="pubmed">34633405</ArticleId></ArticleIdList></Reference><Reference><Citation>Sholzberg M., Tang G.H., Rahhal H., et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. Bmj. 2021;375</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515466</ArticleId><ArticleId IdType="pubmed">34649864</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Ochoa A.J., Raffetto J.D., Hern&#xe1;ndez A.G., et al. Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial. Thromb Haemost. 2021;121(7):944&#x2013;954.</Citation><ArticleIdList><ArticleId IdType="pubmed">33677827</ArticleId></ArticleIdList></Reference><Reference><Citation>Leucker T.M., Osburn W.O., Reventun P., et al. Effect of crizanlizumab, a P-selectin inhibitor, in COVID-19: a placebo-controlled, randomized trial. JACC Basic Transl Sci. 2021;6(12):935&#x2013;945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653991</ArticleId><ArticleId IdType="pubmed">34904132</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes R.D., Macedo A.V.S., de Barros E.S.P.G.M., et al. Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial. JAMA. 2021;325(3):254&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816106</ArticleId><ArticleId IdType="pubmed">33464336</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaral A.F., Salge J.M., Kalil Filho R., et al. Acute exacerbation of post-COVID-19 pulmonary fibrosis: air travel as a potential trigger. J Bras Pneumol. 2021;47(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013524</ArticleId><ArticleId IdType="pubmed">34669835</ArticleId></ArticleIdList></Reference><Reference><Citation>Foged F., Rasmussen I.E., Bj&#xf8;rn Budde J., et al. Fidelity, tolerability and safety of acute high-intensity interval training after hospitalisation for COVID-19: a randomised cross-over trial. BMJ Open Sport Exerc Med. 2021;7(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8413475</ArticleId><ArticleId IdType="pubmed">34493958</ArticleId></ArticleIdList></Reference><Reference><Citation>Poncin W., Schalkwijk A., Vander Straeten C., et al. Impact of surgical mask on performance and cardiorespiratory responses to submaximal exercise in COVID-19 patients near hospital discharge: a randomized crossover trial. Clin Rehabil. 2022;36(8):1032&#x2013;1041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047665</ArticleId><ArticleId IdType="pubmed">35473371</ArticleId></ArticleIdList></Reference><Reference><Citation>Cenko E., Badimon L., Bugiardini R., et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC working group on Coronary Pathophysiology &amp; Microcirculation, ESC working group on thrombosis and the Association for Acute CardioVascular care (ACVC), in collaboration with the European heart rhythm association (EHRA) Cardiovasc Res. 2021;117(14):2705&#x2013;2729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500019</ArticleId><ArticleId IdType="pubmed">34528075</ArticleId></ArticleIdList></Reference><Reference><Citation>Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">32219363</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerkin K.J., Fried J.A., Raikhelkar J., et al. COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648&#x2013;1655.</Citation><ArticleIdList><ArticleId IdType="pubmed">32200663</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal P., Choi J.J., Pinheiro L.C., et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372&#x2013;2374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182018</ArticleId><ArticleId IdType="pubmed">32302078</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna H., Ryu A.J., Scott C.G., et al. Cardiac abnormalities in COVID-19 and relationship to outcome. Mayo Clin Proc. 2021;96(4):932&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816643</ArticleId><ArticleId IdType="pubmed">33714597</ArticleId></ArticleIdList></Reference><Reference><Citation>Umbrajkar S., Stankowski R.V., Rezkalla S., Kloner R.A. Cardiovascular health and disease in the context of COVID-19. Cardiol Res. 2021;12(2):67&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7935632</ArticleId><ArticleId IdType="pubmed">33738009</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik T.J., Mohiddin S.A., Dimarco A., et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666&#x2013;1687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Barco S., Voci D., Held U., et al. Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial. Lancet Haematol. 2022;9(8):e585&#x2013;e593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9243568</ArticleId><ArticleId IdType="pubmed">35779558</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S., Abbafati C., Aerts J.G., et al. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv. 2022</Citation></Reference><Reference><Citation>Cutler D.M. The costs of Long COVID. JAMA Health Forum. 2022;3(5):e221809.</Citation><ArticleIdList><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghy M.A., Owen R., Thomas C., et al. Is long COVID the next global health crisis? Journal of. Glob Health. 2022:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9597397</ArticleId><ArticleId IdType="pubmed">36285549</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesce M., Agostoni P., B&#xf8;tker H.E., et al. COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC working group on cellular biology of the heart. Cardiovasc Res. 2021;117(10):2148&#x2013;2160.</Citation><ArticleIdList><ArticleId IdType="pubmed">34117887</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghy M.A., Maden-Wilkinson T., Arena R., et al. COVID-19 patients require multi-disciplinary rehabilitation approaches to address persisting symptom profiles and restore pre-COVID quality of life. Expert Rev Respir Med. 2022;16(5):595&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">35385677</ArticleId></ArticleIdList></Reference><Reference><Citation>Faghy M.A., Arena R., Stoner L., et al. The need for exercise sciences and an integrated response to COVID-19: a position statement from the international HL-PIVOT network. Prog Cardiovasc Dis. 2021;67:2&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859729</ArticleId><ArticleId IdType="pubmed">33549590</ArticleId></ArticleIdList></Reference><Reference><Citation>Arena R., Myers J., Kaminsky L.A., et al. Current activities centered on healthy living and recommendations for the future: a position statement from the HL-PIVOT network. Curr Probl Cardiol. 2021;46(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9587486</ArticleId><ArticleId IdType="pubmed">33789171</ArticleId></ArticleIdList></Reference><Reference><Citation>Tronco Hern&#xe1;ndez Y.A., Parente F., Faghy M.A., Roscoe C.M.P., Maratos F.A. Influence of the COVID-19 lockdown on the physical and psychosocial well-being and work productivity of remote workers: cross-sectional correlational study. JMIRx Med. 2021;2(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8641476</ArticleId><ArticleId IdType="pubmed">34898665</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratton C.W., Tang Y.W., Lu H. Pathogenesis-directed therapy of 2019 novel coronavirus disease. J Med Virol. 2021;93(3):1320&#x2013;1342.</Citation><ArticleIdList><ArticleId IdType="pubmed">33073355</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira D.O.A.V., Viana A.A., Heubel A.D., et al. Cardiovascular, respiratory, and functional effects of home-based exercise training after COVID-19 hospitalization. Med Sci Sports Exerc. 2022;54(11):1795&#x2013;1803.</Citation><ArticleIdList><ArticleId IdType="pubmed">35714077</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>